KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash from Financing Activities (2016 - 2026)

Pfizer has reported Cash from Financing Activities over the past 18 years, most recently at -$2.9 billion for Q1 2026.

  • Quarterly Cash from Financing Activities rose 45.36% to -$2.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$7.9 billion through Mar 2026, up 67.81% year-over-year, with the annual reading at -$10.3 billion for FY2025, 39.88% up from the prior year.
  • Cash from Financing Activities was -$2.9 billion for Q1 2026 at Pfizer, down from $596.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $27.2 billion in Q3 2023 and troughed at -$12.0 billion in Q3 2024.
  • The 5-year median for Cash from Financing Activities is -$2.9 billion (2026), against an average of -$1.4 billion.
  • Year-over-year, Cash from Financing Activities soared 978.33% in 2023 and then plummeted 218.23% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$9.8 billion in 2022, then skyrocketed by 155.42% to $5.4 billion in 2023, then crashed by 320.98% to -$12.0 billion in 2024, then soared by 104.96% to $596.0 million in 2025, then tumbled by 579.19% to -$2.9 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Cash from Financing Activities are -$2.9 billion (Q1 2026), $596.0 million (Q4 2025), and -$2.5 billion (Q3 2025).